Dishman Carbogen Amcis Ltd

NSE: DCAL · BSE: 540701 · Pharmaceuticals & Biotechnology · 38 announcements

Share price: ₹152.41
Market cap: ₹2,390 Cr
Revenue (annual): ₹2,932 Cr
Net profit (annual): ₹97.45 Cr
P/E (TTM): 147.9×Sector 47.4×
Promoter holding: 59.32%+0.00% QoQ
FII holding: 6.86%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Debt & Borrowing 7 Other Announcement 2 Management Change 1 Financial Results 1 Earnings Call 1 Business Update 1 Board Meeting Date 1 Annual Report 1 Annual General Meeting 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

2 announcements with these filters

14 Aug 2026 20:08 IST BSE

Other Announcement

Dishman Carbogen Amcis Other Announcement

Dishman Carbogen Amcis Ltd submitted a statement confirming the utilization of proceeds from non-convertible debt securities issued on June 9, 2026, with no deviations.

Read the filing ↗

21 Jul 2026 15:58 IST BSE

Other Announcement

Dishman Carbogen Amcis Other Announcement

Dishman Carbogen Amcis Ltd filed its quarterly shareholding pattern for the quarter ended June 30, 2026. The disclosure includes notes regarding promoter group changes and SBO details.

Read the filing ↗